Learn about how mutations in EGFR can affect patients with metastatic NSCLC
Learn more about the people involved in EGFR mutation testing as well as the diagnostics available to test at initial diagnosis
Understand how NSCLC tumors may adapt over time and the importance of retesting for EGFR mutations at disease progression
Review FDA-approved and CLIA-validated diagnostics available for EGFR mutation testing
Understand the sample types acceptable for EGFR mutation testing, including tissue- and plasma-based samples
Learn more about how to read an EGFR mutation test report, and review key communication points to discuss with your patients
From your mobile device, you will be able to access the modules but cannot access the quiz pages and get certification. We strongly recommend you to Register/Login from either desktop or tablet device.
If you would like additional information regarding AstraZeneca products, please contact the Information Center at AstraZeneca in the United States at 1-800-236-9933, Monday through Friday, 8 AM to 6 PM ET, excluding holidays.